Creative Planning Increases Stake in Kimberly-Clark Co. (NYSE:KMB)

Creative Planning grew its holdings in shares of Kimberly-Clark Co. (NYSE:KMB) by 1.3% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 75,147 shares of the company’s stock after buying an additional 943 shares during the period. Creative Planning’s holdings in Kimberly-Clark were worth $10,692,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. William B. Walkup & Associates Inc. bought a new position in shares of Kimberly-Clark during the second quarter valued at $26,000. Crewe Advisors LLC purchased a new stake in shares of Kimberly-Clark during the first quarter worth about $27,000. New Millennium Group LLC bought a new position in Kimberly-Clark during the second quarter valued at approximately $28,000. Strategic Financial Concepts LLC bought a new position in Kimberly-Clark during the second quarter valued at approximately $32,000. Finally, ORG Wealth Partners LLC bought a new position in Kimberly-Clark during the third quarter valued at approximately $39,000. 76.29% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. Argus raised Kimberly-Clark to a “hold” rating in a research note on Friday, July 26th. Piper Sandler lifted their price target on Kimberly-Clark from $167.00 to $174.00 and gave the company an “overweight” rating in a report on Thursday, July 11th. Royal Bank of Canada reissued an “outperform” rating and issued a $165.00 price objective on shares of Kimberly-Clark in a research report on Wednesday, July 24th. Barclays lifted their price target on Kimberly-Clark from $135.00 to $144.00 and gave the stock an “equal weight” rating in a research report on Friday, October 11th. Finally, JPMorgan Chase & Co. lifted their price target on Kimberly-Clark from $137.00 to $142.00 and gave the stock an “underweight” rating in a research report on Friday, October 11th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $149.14.

Kimberly-Clark Stock Performance

NYSE:KMB opened at $137.75 on Wednesday. The company’s 50-day moving average price is $143.26 and its 200-day moving average price is $138.67. The company has a current ratio of 0.85, a quick ratio of 0.58 and a debt-to-equity ratio of 5.59. The company has a market cap of $46.38 billion, a P/E ratio of 25.32, a P/E/G ratio of 2.98 and a beta of 0.39. Kimberly-Clark Co. has a twelve month low of $116.63 and a twelve month high of $149.30.

Kimberly-Clark (NYSE:KMB) last announced its quarterly earnings data on Tuesday, July 23rd. The company reported $1.96 earnings per share for the quarter, beating analysts’ consensus estimates of $1.71 by $0.25. The firm had revenue of $5.03 billion during the quarter, compared to analysts’ expectations of $5.10 billion. Kimberly-Clark had a net margin of 11.28% and a return on equity of 223.55%. The business’s quarterly revenue was down 2.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.65 earnings per share. On average, sell-side analysts forecast that Kimberly-Clark Co. will post 7.25 earnings per share for the current fiscal year.

Kimberly-Clark Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 2nd. Shareholders of record on Friday, September 6th were issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.54%. The ex-dividend date was Friday, September 6th. Kimberly-Clark’s dividend payout ratio (DPR) is presently 89.71%.

Insiders Place Their Bets

In other news, insider Gonzalo Uribe sold 1,780 shares of the business’s stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $140.84, for a total transaction of $250,695.20. Following the completion of the sale, the insider now owns 7,377 shares in the company, valued at approximately $1,038,976.68. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other Kimberly-Clark news, insider Gonzalo Uribe sold 1,780 shares of the business’s stock in a transaction on Monday, July 29th. The shares were sold at an average price of $140.84, for a total value of $250,695.20. Following the transaction, the insider now directly owns 7,377 shares of the company’s stock, valued at approximately $1,038,976.68. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Jeffrey P. Melucci sold 37,699 shares of the company’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $141.42, for a total transaction of $5,331,392.58. Following the transaction, the insider now directly owns 19,935 shares in the company, valued at approximately $2,819,207.70. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.62% of the stock is currently owned by company insiders.

Kimberly-Clark Company Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.